BiondVax Pharmaceuticals LtdNASDAQ:BVXV
- LAST PRICE2.7500
- TODAY'S CHANGE (%)0.1050 (3.9698%)
- Bid / Lots2.7000/ 14
- Ask / Lots2.8500/ 15
- Open / Previous Close2.6300 / 2.6450
- Day Range
- 52 Week Range
- Volume174,043
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BVXV |
|---|---|---|
| 09:32 ET | 196 | 2.63 |
| 09:33 ET | 800 | 2.69 |
| 09:35 ET | 500 | 2.69 |
| 09:37 ET | 1900 | 2.6501 |
| 09:42 ET | 3100 | 2.65 |
| 09:44 ET | 521 | 2.68 |
| 09:46 ET | 4300 | 2.68 |
| 09:48 ET | 3600 | 2.65 |
| 09:50 ET | 6935 | 2.6201 |
| 09:51 ET | 1200 | 2.68 |
| 09:53 ET | 1181 | 2.681 |
| 09:57 ET | 1500 | 2.6781 |
| 10:00 ET | 698 | 2.7 |
| 10:02 ET | 1100 | 2.671 |
| 10:04 ET | 420 | 2.68 |
| 10:06 ET | 400 | 2.6801 |
| 10:09 ET | 5900 | 2.623 |
| 10:13 ET | 500 | 2.68 |
| 10:15 ET | 1400 | 2.6601 |
| 10:18 ET | 100 | 2.65 |
| 10:20 ET | 450 | 2.67 |
| 10:24 ET | 2800 | 2.6433 |
| 10:31 ET | 1015 | 2.6306 |
| 10:33 ET | 6203 | 2.62 |
| 10:36 ET | 7595 | 2.59 |
| 10:40 ET | 100 | 2.6474 |
| 10:45 ET | 2210 | 2.64 |
| 10:47 ET | 1080 | 2.68 |
| 10:54 ET | 995 | 2.68 |
| 10:58 ET | 400 | 2.68 |
| 11:00 ET | 6160 | 2.73 |
| 11:02 ET | 2000 | 2.7015 |
| 11:03 ET | 500 | 2.7 |
| 11:05 ET | 100 | 2.71 |
| 11:07 ET | 100 | 2.71 |
| 11:09 ET | 1700 | 2.72 |
| 11:12 ET | 1700 | 2.71 |
| 11:16 ET | 1100 | 2.72 |
| 11:18 ET | 100 | 2.715 |
| 11:20 ET | 600 | 2.71 |
| 11:30 ET | 400 | 2.715 |
| 11:32 ET | 2350 | 2.7037 |
| 11:34 ET | 900 | 2.72 |
| 11:36 ET | 1064 | 2.71 |
| 11:38 ET | 1600 | 2.7101 |
| 11:39 ET | 1200 | 2.7 |
| 11:48 ET | 600 | 2.71 |
| 11:54 ET | 800 | 2.71 |
| 11:56 ET | 6650 | 2.71 |
| 11:57 ET | 100 | 2.71 |
| 11:59 ET | 100 | 2.72 |
| 12:03 ET | 1100 | 2.73 |
| 12:06 ET | 2600 | 2.7305 |
| 12:08 ET | 2600 | 2.7101 |
| 12:12 ET | 2500 | 2.7299 |
| 12:14 ET | 2400 | 2.73 |
| 12:15 ET | 1800 | 2.7301 |
| 12:17 ET | 4500 | 2.7301 |
| 12:19 ET | 100 | 2.74 |
| 12:21 ET | 1969 | 2.73 |
| 12:28 ET | 2420 | 2.74 |
| 12:30 ET | 300 | 2.7475 |
| 12:32 ET | 100 | 2.745 |
| 12:33 ET | 600 | 2.7472 |
| 12:35 ET | 327 | 2.75 |
| 12:39 ET | 120 | 2.78 |
| 12:42 ET | 600 | 2.82 |
| 12:46 ET | 2990 | 2.76 |
| 12:48 ET | 1869 | 2.73 |
| 01:00 ET | 200 | 2.73 |
| 01:20 ET | 1000 | 2.755 |
| 01:33 ET | 912 | 2.75 |
| 01:36 ET | 320 | 2.7638 |
| 01:40 ET | 841 | 2.7699 |
| 01:47 ET | 101 | 2.75 |
| 01:49 ET | 100 | 2.7485 |
| 01:51 ET | 1209 | 2.75 |
| 02:00 ET | 2200 | 2.77 |
| 02:02 ET | 905 | 2.76 |
| 02:05 ET | 392 | 2.77 |
| 02:07 ET | 6000 | 2.8 |
| 02:12 ET | 300 | 2.7997 |
| 02:20 ET | 1422 | 2.8 |
| 02:21 ET | 1449 | 2.84 |
| 02:23 ET | 600 | 2.84 |
| 02:27 ET | 500 | 2.8352 |
| 02:32 ET | 3200 | 2.81 |
| 02:34 ET | 325 | 2.81 |
| 02:41 ET | 2978 | 2.7566 |
| 02:48 ET | 2000 | 2.7504 |
| 02:50 ET | 1462 | 2.7501 |
| 02:52 ET | 1600 | 2.7401 |
| 02:56 ET | 1371 | 2.74 |
| 02:57 ET | 500 | 2.741 |
| 03:03 ET | 565 | 2.7499 |
| 03:06 ET | 500 | 2.75 |
| 03:10 ET | 4708 | 2.7262 |
| 03:14 ET | 2000 | 2.7201 |
| 03:17 ET | 300 | 2.72 |
| 03:19 ET | 100 | 2.75 |
| 03:26 ET | 536 | 2.7463 |
| 03:28 ET | 1000 | 2.7201 |
| 03:39 ET | 150 | 2.735 |
| 03:42 ET | 200 | 2.735 |
| 03:53 ET | 900 | 2.75 |
| 03:57 ET | 1400 | 2.75 |
Jan 23, 2023
BRIEF-BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevents Illness In Vivo Study, from 7:45AM ET on Monday Jan 23, 2023 by Thomson Reuters
7:45AM ET on Monday Jan 23, 2023 by Thomson Reuters
Jan 6, 2023
BiondVax Says Its COVID-19 Treatment Candidate Lowered Presence of Coronavirus in Animal Study, from 8:22AM ET on Friday Jan 06, 2023 by MT Newswires
8:22AM ET on Friday Jan 06, 2023 by MT NewswiresBRIEF-Biondvax’S Innovative Inhaled Covid-19 Therapy Virtually Eliminates Sars-Cov-2 Virus In Preclinical Study, from 7:15AM ET on Friday Jan 06, 2023 by Thomson Reuters
7:15AM ET on Friday Jan 06, 2023 by Thomson ReutersBiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study, from 7:15AM ET on Friday Jan 06, 2023 by GlobeNewswire
7:15AM ET on Friday Jan 06, 2023 by GlobeNewswire
Jan 5, 2023
BiondVax to Present at Biotech Showcase 2023, from 7:00AM ET on Thursday Jan 05, 2023 by GlobeNewswire
7:00AM ET on Thursday Jan 05, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BiondVax Pharmaceuticals Ltd | 5.0M | -0.5x | --- |
CTT Pharmaceutical Holdings Inc | 1.5M | -0.4x | --- |
Rasna Therapeutics Inc | 1.8M | -0.8x | --- |
Cell MedX Corp | 1.8M | -2.0x | --- |
Adhera Therapeutics Inc | 1.8M | -0.2x | --- |
Scopus Biopharma Inc | 1.9M | -0.1x | --- |
Company Information
BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing and commercializing of innovative products for the prevention and treatment of infectious diseases but also for other illnesses. BiondVax Pharmaceuticals Ltd core focus is to develop of NanoAbs for treatment of COVID-19, psoriasis and asthma. Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally the Company offers manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for other research and development companies. BiondVax Pharmaceuticals Ltd operates in Israel.
Contact Information
- Headquarters
- Jerusalem Biopark 2Nd Floor, Hadassah Ein Kerem CampusJERUSALEM, Israel 00000
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Mark Germain
- Chief Executive Officer, Director
- Amir Reichman
- Chief Financial Officer
- Uri Ben-Or
- Chief Operating Officer
- Elad Mark
- Chief Scientific Officer
- Tamar Ben-Yedidia
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 4.7K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.54 |
EPS | $-5.61 |
Book Value | $3.75 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
